Doing a certain amount of exercise is linked to a 30% to 40% lower risk of an early death from any cause, according to a new ...

A meta-analysis of 187 trials shows that Paxlovid and remdesivir reduce the risk for hospitalization in patients with mild-to ...

In patients with metabolic-associated steatotic liver disease or metabolic-associated steatohepatitis, resmetirom and ...

The National Cancer Institute and University of Oxford report that oral contraceptive use is not associated with increased ...

A massive meta-analysis shows staying active throughout adulthood can slash death risk by up to 40%. Learn why consistency matters more than perfection.

Dr. Carrie Jose, in her latest Health and Wellness column, explains what you need to know before you try Platelet-Rich Plasma ...

Infliximab and efzofitimod may be effective in pulmonary sarcoidosis and tofacitinib and adalimumab in cutaneous sarcoidosis.

In recent years, the application of picosecond laser (PSL) treatment for skin discoloration caused by nevus of Ota has been ...

Sonelokimab, adalimumab, lutikizumab, and bimekizumab are the top-rated treatments for moderate-to-severe HS, a network ...

Of 1.3 million participants in the MWS with a median follow-up of 21.4 years, 2,765 (o.21%) developed liver cancer, with no ...

A large network meta-analysis ranked eight GLP-1 receptor agonists for glycemic, weight, and safety outcomes in adults with ...

Doctors are at higher risk of depression, anxiety and suicide than almost any other profession. Now, a global review led by ...